Showing results (71-80 of 227) with videos related to

Sort By:
Pageof 23
Pharmaceutical Research|August 9, 2011
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparinAbhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
Clinical Toxicology (Philadelphia, Pa.)|August 23, 2011
A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdoseFinna Shen, Carolyn V Coulter, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|November 18, 2009
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising eventsMichael A Barras, Stephen B Duffull, John J Atherton, et al.
Therapeutic Drug Monitoring|July 2, 2010
Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrationsMichael A Barras, Stephen B Duffull, John J Atherton, et al.
Pharmaceutical Research|July 2, 2015
Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for EnoxaparinAbhishek Gulati, James M Faed, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|November 12, 2020
Sulfate conjugation may be the key to hepatotoxicity in paracetamol overdoseJingyun Li, Angela L Chiew, Geoffrey K Isbister, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 25, 2005
Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patientsTimothy H Waterhouse, Stefanie Redmann, Stephen B Duffull, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 3, 2021
Population pharmacokinetics of immediate-release and modified-release paracetamol and its major metabolites in a supratherapeutic dosing studyJingyun Li, Angela L Chiew, Geoffrey K Isbister, et al.
The AAPS Journal|July 21, 2018
Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population GroupYevgen Ryeznik, Oleksandr Sverdlov, Andrew C Hooker
The AAPS Journal|December 30, 2017
Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event OutcomesYevgen Ryeznik, Oleksandr Sverdlov, Andrew C Hooker
Pageof 23